Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-23-000101

Options or other derivatives

  • Chief People Officer acquired 120,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Schick Kelly Chief People Officer 2023-09-18 Grant or award · Stock Option (Right to Buy) +120,000 120,000 D
Loading xslF345X05/wk-form4_1695165826.xml…